Quoin Pharmaceuticals Future Growth
Future criteria checks 0/6
Quoin Pharmaceuticals is forecast to grow earnings and revenue by 62.8% and 52.8% per annum respectively while EPS is expected to grow by 72.2% per annum.
Key information
62.8%
Earnings growth rate
72.2%
EPS growth rate
Biotechs earnings growth | 23.2% |
Revenue growth rate | 52.8% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 27 Mar 2024 |
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 31 | -1 | N/A | N/A | 2 |
12/31/2025 | 16 | -10 | N/A | N/A | 1 |
12/31/2024 | N/A | -9 | N/A | N/A | 2 |
12/31/2023 | N/A | -9 | -8 | -8 | N/A |
9/30/2023 | N/A | -9 | -7 | -7 | N/A |
6/30/2023 | N/A | -10 | -8 | -8 | N/A |
3/31/2023 | N/A | -10 | -8 | -8 | N/A |
12/31/2022 | N/A | -9 | -8 | -8 | N/A |
9/30/2022 | N/A | -19 | -10 | -10 | N/A |
6/30/2022 | N/A | -18 | -8 | -8 | N/A |
3/31/2022 | N/A | -19 | -7 | -7 | N/A |
12/31/2021 | N/A | -21 | -6 | -6 | N/A |
9/30/2021 | N/A | -11 | -3 | -3 | N/A |
6/30/2021 | N/A | -10 | -2 | -2 | N/A |
3/31/2021 | N/A | -6 | -1 | -1 | N/A |
12/31/2020 | N/A | -2 | -1 | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: QNRX is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: QNRX is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: QNRX is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: QNRX is forecast to have no revenue next year.
High Growth Revenue: QNRX is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if QNRX's Return on Equity is forecast to be high in 3 years time